Dallas, TX, March 17, 2017 --(PR.com
)-- APAC Sports Medicine Market is expected to reach USD 9.3 billion by 2024 from USD 3.7 billion in 2016, at a CAGR of 12.2% in the forecast period 2017 to 2024.
The market is segmented on the basis of Product Type, Body Area, End-User, Type and Region.
On the basis of product type the market is segmented into Orthobiologics, surgical devices, arthroscopy devices and orthopedic braces and supports. Orthobiologics are biomaterials or synthetic used as fillers or separately to align or reconstruct broken bones. They are widely used in the treatment of sports injuries such as ACL tear and others.
On the basis of body area into knee, hip, shoulder and elbow, foot and ankle and, hand and wrist. The hip and knee segment is expected to dominate the market with more than 55% market share in 2017, and this trend is expected to continue in the forecasted years 2017 to 2024.
Request for sample pages: https://databridgemarketresearch.com/reports/asia-pacific-sports-medicine-market-trends-forecast-2024/
Based on end-users the market is segmented into hospitals, orthopedic clinics, ambulatory surgical centers and others. The orthopedic clinics segment is expected to hold the major share of this market in 2015, owing to increased day care surgeries over inpatient arthroscopy procedures in developed markets.
Based on region the market is segmented into 8 regions, Japan, Australia, China, India, Singapore, Malaysia, Thailand and Others. Japan being the one of the forerunner in advanced cellular therapies used in sports medicine is expected to fuel the growth of the Asia-Pacific Sports medicine market.
Based on geography the Asia-Pacific sports medicine market is segmented into 7 countries, China, India, Japan, South Korea, Singapore, Australia and rest of APAC. Japan is expected to dominate the market in 2016, and will continue to be the leader in the forecast period 2017 to 2024. Asia Pacific is expected to grow at the highest CAGR, owing to the increasing incidence of sports injuries in China, India, South Korea and ASEAN regions. Also Japan being the one of the forerunner in advanced cellular therapies used in sports medicine is expected to fuel the growth of the Asia-Pacific Sports medicine market.
Read more: https://databridgemarketresearch.com/asia-pacific-sports-medicine-market-expected-reach-usd-7-4/
Some of the major players operating in this market are Arthrex, Inc., Smith and Nephew, Medtronic, Depuy Synthes, Stryker, Conmed Corporation, Zimmer, Inc., Japan MDM, Inc., DJO Global, Ossur Corporate, Ottobock Healthcare GmbH, Breg, Inc., Tornier, Inc., Mueller Sports Medicine, Inc., Cramer Products, Inc., RTI Surgical among others.
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Office Number 317, Amanora Chambers,
Magarpatta Road, Hadapsar
Pune – 411028
Toll Free: +1-888-387-2818